Does BROMAZEPAM Cause Psychomotor hyperactivity? 54 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Psychomotor hyperactivity have been filed in association with BROMAZEPAM. This represents 0.9% of all adverse event reports for BROMAZEPAM.
54
Reports of Psychomotor hyperactivity with BROMAZEPAM
0.9%
of all BROMAZEPAM reports
0
Deaths
36
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From BROMAZEPAM?
Of the 54 reports, 36 (66.7%) required hospitalization, and 5 (9.3%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROMAZEPAM. However, 54 reports have been filed with the FAERS database.
What Other Side Effects Does BROMAZEPAM Cause?
Drug abuse (964)
Toxicity to various agents (914)
Coma (790)
Somnolence (641)
Intentional overdose (467)
Poisoning deliberate (419)
Fall (385)
Hypotension (375)
Drug use disorder (351)
Suicide attempt (345)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which BROMAZEPAM Alternatives Have Lower Psychomotor hyperactivity Risk?
BROMAZEPAM vs BROMFENAC
BROMAZEPAM vs BROMHEXINE
BROMAZEPAM vs BROMOCRIPTINE
BROMAZEPAM vs BROTIZOLAM
BROMAZEPAM vs BUCILLAMINE